CYTOKINETICS INCORPOR
50.25
25-November-24 16:45:01
15 minutes delayed
Stocks
+1.15
+2.34%
Today's range
49.45 - 51.11
ISIN
N/A
Source
NASDAQ
-
Cytokinetics Announces Outcome of FDA Advisory Committee Vote On Omecamtiv Mecarbil
13 Dec 2022 17:45:52 By Nasdaq GlobeNewswire
-
Cytokinetics Stock Trading Halted Today
13 Dec 2022 07:02:16 By Nasdaq GlobeNewswire
-
09 Dec 2022 08:59:34 By Nasdaq GlobeNewswire
-
Cytokinetics Presents Data at the Virtual 33rd International Symposium on ALS/MND
08 Dec 2022 07:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3828136
07 Dec 2022 07:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Dec 2022 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Presentation at the Virtual 33rd International Symposium on ALS/MND
01 Dec 2022 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Presents New Data at the American Heart Association Scientific Sessions 2022
07 Nov 2022 07:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics Reports Third Quarter 2022 Financial Results
03 Nov 2022 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Nov 2022 16:00:00 By Nasdaq GlobeNewswire
-
31 Oct 2022 07:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics to Announce Third Quarter Results on November 3, 2022
20 Oct 2022 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Continuation of COURAGE-ALS Following First Interim Analysis
10 Oct 2022 07:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Oct 2022 16:00:00 By Nasdaq GlobeNewswire
-
02 Oct 2022 09:45:00 By Nasdaq GlobeNewswire
-
30 Sep 2022 10:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Call for Proposals for Its Fifth Annual Communications Grant Program
28 Sep 2022 07:30:00 By Nasdaq GlobeNewswire
-
26 Sep 2022 07:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics to Participate in Upcoming Investor Conferences
06 Sep 2022 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Sep 2022 16:00:00 By Nasdaq GlobeNewswire